(Q86424890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Intravitreal bevacizumab treatment for refractory diabetic macular edema (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

diabetic macular edema

1 reference

Erdem Yuksel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Sengul Ozdek

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Nılay Yuksel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Berati Hasanreisoglu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

19 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

International Ophthalmology

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

659-663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23508574%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10792-013-9758-y

26 February 2020

exact match

0 references

cites work

Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy

1 reference

12 December 2020

Intravitreal injection of triamcinolone for diffuse diabetic macular edema

1 reference

12 December 2020

Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?

1 reference

12 December 2020

Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab

1 reference

12 December 2020

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema

1 reference

12 December 2020

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

1 reference

12 December 2020

Repeated intravitreal injection of bevacizumab for clinically significant diabetic macular edema

1 reference

12 December 2020

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

1 reference

12 December 2020

Predicted biologic activity of intravitreal bevacizumab.

1 reference

12 December 2020

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

1 reference

12 December 2020

Cystoid macular edema

1 reference

12 December 2020

Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.

1 reference

12 December 2020

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

1 reference

12 December 2020

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

12 December 2020

Short-term response of macular oedema to intravitreal bevacizumab

1 reference

12 December 2020

Complications of intravitreal injections

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

1 reference

12 December 2020

VEGF-initiated blood-retinal barrier breakdown in early diabetes.

1 reference

12 December 2020

Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema

1 reference

12 December 2020

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

1 reference

12 December 2020

Pharmacokinetics of intravitreal bevacizumab (Avastin)

1 reference

12 December 2020

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study

1 reference

12 December 2020

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

12 December 2020